Gator Bio

Gator Bio prevailed at the ITC after a full hearing and later secured dismissal of infringement claims in federal court. Sartorius began its U.S. International Trade Commission case by asserting claims from four U.S. patents against Gator Bio's BLI produc

Gator Bio, a pioneer in biolayer interferometry (BLI) technologies, has launched its new Gator HIS XT Probes-the first BLI probes to incorporate AI-designed binding proteins. Developed in partnership with Monod Bio, the HIS XT probes feature Monod's propr

Gator Bio and Hudson Lab Automation announce a proven integrated solution for high-throughput antibody discovery, tripling BLI assay throughput to 1,200+ samples per day. Showcased at SLAS 2026, the collaboration enables AI-driven drug discovery, scalable

Seattle, WA & Palo Alto, CA - December 3, 2025 - Monod Bio, a leader in computational protein design, and Gator Bio, a pioneer in biolayer interferometry (BLI) technologies, today announced a partnership to integrate one of Monod's proprietary AI-designed

The post Gator Bio Launches Gator Pilot and Gator Pivot Biolayer Interferometry Systems for Biotherapeutics Discovery appeared first on Gator Bio.

PALO ALTO, Calif., July 6, 2023 - An Administrative Law Judge at the United States International Trade Commission (USITC) has announced the termination of the Section 337 investigation involving certain biolayer interferometers and components. In October

Investigation Terminated After Remaining Patent Claims Found Invalid ITC grants summary determination, ruling claims 8, 16, and 18 of the '887 patent invalid for indefiniteness. In October 2022, Sartorius BioAnalytical Instruments, Inc., manufacturer of t

Gator Bio in partnership with GeneX India Bioscience is ready to serve the biotherapeutics research and manufacturing with next-gen biolayer interferometry PALO ALTO, CA, UNITED STATES, April 18, 2023/EINPresswire.com/ - Gator Bio, the next-gen biolayer i

Gator Bio launches Gator Pro, a high throughput and high performance next-gen BLI system, for biotherapeutics discovery NEWS PROVIDED BY Gator Bio January 13, 2023, 20:46 GMT Gator Bio aims to set a new industry standard for high throughput and accurate k

The AAV Titer and Empty/Full Ratio Determination in Upstream Crude Samples is Challenging. The New Gator Assays Offer a Practical Cost-Effective Solution SAN JOSE, CA, UNITED STATES, November 15, 2022 /EINPresswire.com/ - Today, Gator Bio, Inc. announced